Stock Taper
EARNINGS CALL ARCHIVE 1 CALL ON FILE
TXMD — TherapeuticsMD, Inc.
NASDAQ
FULL STOCK PAGE →

Q2 2022 Earnings Call Summary

AUG 15, 2022
REVENUE
$28.6M +47.7%
NET MARGIN
393.1% +764.6 PTS
EPS
$12.83 +253.5%
FREE CASH FLOW
-$15.5M +47.9%

No summary has been written for this call yet.